This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. rose 3.2% to $1.91 on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index falling 0.3% to 21,100.31 and Dow Jones Industrial Average falling 0.3% to 44,785.50.
Inovio Pharmaceuticals Inc. closed 75.4% below its 52-week high of $7.76, which the company reached on August 23rd.
The stock demonstrated a mixed performance when compared to some of its competitors, as Johnson & Johnson rose 0.1% to $178.93, Statera Biopharma Inc. rose 100.0% to $0.00, and Pfizer Inc. rose 1.42% to $25.74.
Trading volume totaled 1.1 million, compared to the 50-day average of 2.2 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
August 21, 2025 16:34 ET (20:34 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.